Published in Infect Immun on October 01, 1979
Synergistic interaction between interferon-alpha and interferon-gamma through induced synthesis of one subunit of the transcription factor ISGF3. EMBO J (1990) 2.75
Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest (1985) 2.28
Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells. Nucleic Acids Res (1982) 2.01
Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. J Virol (1984) 1.60
Transcriptional analyses of interferon-inducible mRNAs. Mol Cell Biol (1987) 1.50
Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun (1983) 1.45
Regulation of synthesis and turnover of an interferon-inducible mRNA. Mol Cell Biol (1986) 1.43
Regulation of the interferon-inducible IFI-78K gene, the human equivalent of the murine Mx gene, by interferons, double-stranded RNA, certain cytokines, and viruses. J Virol (1989) 1.24
Automated, quantitative cytopathic effect reduction assay for interferon. J Clin Microbiol (1982) 1.22
High-level induction of gamma interferon with various mitogens in mice pretreated with Propionibacterium acnes. Infect Immun (1982) 1.14
Expression of interferon-inducible genes in RD-114 cells. J Virol (1987) 1.08
Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. Infect Immun (1983) 1.04
Induction of an inhibitor of interferon action in a mouse lymphokine preparation. Infect Immun (1979) 1.03
HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion. J Immunol (2009) 1.02
Rapid, quantitative, semiautomated assay for virus-induced and immune human interferons. J Clin Microbiol (1980) 1.01
Natural killer cell activation and interferon production by peripheral blood lymphocytes after exposure to bacteria. Infect Immun (1988) 0.98
Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling. J Immunol (2010) 0.95
Characterization of interferons induced by bacteria and interferon-producing leukocytes in human peripheral blood. Infect Immun (1983) 0.95
Beta and gamma interferons act synergistically to produce an antiviral state in cells resistant to both interferons individually. J Virol (1989) 0.94
Superinduction of the human gene encoding immune interferon. EMBO J (1987) 0.89
Antiviral effects of bovine interferons on bovine respiratory tract viruses. J Clin Microbiol (1984) 0.87
In vitro production of different interferon types by cloned human NK cells. Clin Exp Immunol (1985) 0.82
Induction of gamma-interferon activity by elevated temperatures in human B-lymphoblastoid cell lines. Proc Natl Acad Sci U S A (1984) 0.81
Listeria monocytogenes activation of human peripheral blood lymphocytes: induction of non-major histocompatibility complex-restricted cytotoxic activity and cytokine production. Infect Immun (1992) 0.77
Effects of pure interferons on Epstein-Barr virus infection in vitro. J Virol (1985) 0.76
Biosynthetic human interferon treatment of herpetic keratitis. Trans Am Ophthalmol Soc (1983) 0.75
Posttranscriptional regulation of beta interferon expression in erythroid Friend cells treated with gamma interferon. J Virol (1991) 0.75
Interferon potentiation occurs at a pretranscriptive stage. Infect Immun (1983) 0.75
Stimulation natural cytotoxic activity in mixed cell cultures and by culture supernatants containing interferon. Immunology (1982) 0.75
Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infection. Antimicrob Agents Chemother (1986) 0.75
Alpha interferon: a look to the future. Invest New Drugs (1987) 0.75
Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci U S A (1967) 7.65
Immune specific induction of interferon production in cultures of human blood lymphocytes. Science (1969) 4.43
Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. J Immunol (1973) 3.88
Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin. Science (1965) 3.06
Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. Infect Immun (1973) 2.73
Two antigenically distinct species of human interferon. Proc Natl Acad Sci U S A (1975) 2.59
Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07
INTERFERON. Adv Virus Res (1963) 1.98
Purification of mouse interferon by affinity chromatography on anti-interferon globulin-sepharose. J Immunol (1973) 1.88
High interferon producing line of transformed murine cells. J Gen Virol (1972) 1.79
Large-scale production and partial purification of mouse immune interferon. Infect Immun (1979) 1.57
General considerations of the interferon system. Tex Rep Biol Med (1977) 1.52
Immune interferon activates cells more slowly than does virus-induced interferon. Proc Soc Exp Biol Med (1978) 1.44
Identification of a subpopulation of mouse lymphoid cells required for interferon production after stimulation with mitogens. J Immunol (1974) 1.41
The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response. Cell Immunol (1976) 1.21
Differences in mouse interferons according to cell source and mode of induction. Infect Immun (1977) 1.06
Effect of interferon on virus production from isolated single cells. J Gen Virol (1973) 1.01
Interaction of interferon with cells: induction of antiviral activity. Can J Microbiol (1969) 0.97
Priming of interferon action. Tex Rep Biol Med (1977) 0.87
Inhibitory effect of synthetic polyribonucleotides on the primary in vitro immune response. Proc Soc Exp Biol Med (1975) 0.83
Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity. J Exp Med (1982) 5.33
Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing. J Immunol (1983) 4.38
Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2. J Immunol (1981) 4.04
Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun (1978) 3.01
Staphylococcal enterotoxin B: solid-phase radioimmunoassay. Appl Microbiol (1971) 2.69
The interferons. Mechanisms of action and clinical applications. JAMA (1991) 2.68
Inhibition of the primary in vitro antibody response by interferon preparations. J Immunol (1975) 2.35
Gamma-interferon is one of several direct B cell-maturing lymphokines. Nature (1984) 2.18
Relative ability of mitogens to stimulate production of interferon by lymphoid cells and to induce suppression of the in vitro immune response. Proc Soc Exp Biol Med (1977) 2.07
Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest (1984) 2.00
Large-scale production and physicochemical characterization of human immune interferon. Infect Immun (1979) 1.99
Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation. J Bacteriol (1966) 1.96
The use of a wate-soluble carbodiimide as a coupling reagent in the passive hemagglutination test. J Immunol (1966) 1.94
The effect of staphylococcal enterotoxins on the primary in vitro immune response. J Immunol (1975) 1.88
Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol (1980) 1.85
Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother (1977) 1.79
Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: inhibitory effect of endotoxin. J Immunol (1982) 1.79
Infection of human cell cultures with bovine visna virus. J Gen Virol (1978) 1.70
Staphylococcal enterotoxins A and B: solid-phase radioimmunoassay in food. Appl Microbiol (1973) 1.66
Large-scale production and partial purification of mouse immune interferon. Infect Immun (1979) 1.57
Antigenic cross-reactivity of staphylococcal enterotoxins. Infect Immun (1972) 1.53
Long-term mortality profile of heavily-exposed lead smelter workers. J Occup Med (1982) 1.53
Classification of interferons with antibody to immune interferon. Cell Immunol (1980) 1.49
The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol (1983) 1.46
Stability of 125I-labeled staphylococcal enterotoxins in solid-phase radioimmunoassay. Appl Microbiol (1975) 1.45
Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun (1983) 1.45
Immune interferon activates cells more slowly than does virus-induced interferon. Proc Soc Exp Biol Med (1978) 1.44
Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Natl Acad Sci U S A (1982) 1.44
Simple Eye Tests in a Pediatrician's Office: Their Value. Cal West Med (1937) 1.36
Interleukin 2 regulates immune interferon (IFN gamma) production by normal and suppressor cell cultures. J Immunol (1982) 1.32
Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J Virol (1993) 1.27
Localization of an immune functional site on staphylococcal enterotoxin A using the synthetic peptide approach. J Immunol (1989) 1.25
Enterotoxin B: serological assay in cultures by passive hemagglutination. Appl Microbiol (1967) 1.23
Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma). J Immunol (1981) 1.23
The nature of the suppressive effect of interferon and interferon inducers on the in vitro immune response. Cell Immunol (1976) 1.21
Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence. Cancer Res (1982) 1.18
Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations. J Natl Cancer Inst (1980) 1.14
Leukotrienes: positive signals for regulation of gamma-interferon production. J Immunol (1984) 1.13
Mapping of multiple binding domains of the superantigen staphylococcal enterotoxin A for HLA. J Immunol (1992) 1.13
Differentiation of the immunosuppressive and antiviral effects of interferon. Cell Immunol (1978) 1.13
Immune and virus-induced interferons may activate cells by different derepressional mechanisms. Nature (1980) 1.12
Neutralization of native human gamma interferon (HuIFN gamma) by antibodies to a synthetic peptide encoded by the 5' end of HuIFN gamma cDNA. J Immunol (1982) 1.12
Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules. Proc Natl Acad Sci U S A (1991) 1.09
So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors. Cytokine (2001) 1.08
Gamma interferon (IFN gamma) and IFN alpha/beta suppress murine myeloid colony formation (CFU-C)N: magnitude of suppression is dependent upon level of colony-stimulating factor (CSF). J Immunol (1982) 1.07
Interleukin 2 regulation of mitogen induction of immune interferon (IFN gamma) in spleen cells and thymocytes. Cell Immunol (1982) 1.06
Immune interferon induction by T-cell mitogens involves different T-cell subpopulations. Cell Immunol (1979) 1.06
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells. Cancer Res (2000) 1.06
Regulation of lymphokine (gamma-interferon) production by corticotropin. J Immunol (1984) 1.05
Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. Infect Immun (1983) 1.04
A qualitative comparison of paper flowsheets vs a computer-based clinical information system. Chest (1991) 1.04
The I-A beta b region (65-85) is a binding site for the superantigen, staphylococcal enterotoxin A. Biochem Biophys Res Commun (1990) 1.04
Direct cytolysis by partially-purified preparations of immune interferon. Int J Cancer (1982) 1.04
Induction of an inhibitor of interferon action in a mouse lymphokine preparation. Infect Immun (1979) 1.03
Interleukin 2-mediated events in gamma-interferon production are calcium dependent at more than one site. J Immunol (1985) 1.02
Effect of interferon on virus production from isolated single cells. J Gen Virol (1973) 1.01
Differential nuclear localization of the IFNGR-1 and IFNGR-2 subunits of the IFN-gamma receptor complex following activation by IFN-gamma. J Interferon Cytokine Res (2000) 1.00
Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis. J Neuroimmunol (1993) 1.00
Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A (1993) 1.00
Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1. Biochem Biophys Res Commun (1988) 1.00
Superantigens: the good, the bad, and the ugly. Exp Biol Med (Maywood) (2001) 0.99
Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res (1991) 0.99
Enhanced contrast in electron microscopy of unstained biological material. 3. In-focus phase contrast of large objects. J Microsc (1973) 0.99
Staphylococcal enterotoxin C: solid-phase radioimmunoassay. Appl Microbiol (1975) 0.98
Phorbol ester replacement of helper cell and interleukin 2 requirements in gamma interferon production. Infect Immun (1982) 0.98
Immune-type interferon-induced transfer of viral resistance. J Immunol (1979) 0.97
Interferon: effects on the immune response and the mechanism of activation of the cellular response. CRC Crit Rev Biochem (1976) 0.96
Differential recognition of the type I interferon receptor by interferons tau and alpha is responsible for their disparate cytotoxicities. Proc Natl Acad Sci U S A (1995) 0.96
The COOH-terminal nuclear localization sequence of interferon gamma regulates STAT1 alpha nuclear translocation at an intracellular site. J Cell Sci (2000) 0.96
Interferon inhibition of the primary in vitro antibody response to a thymus-independent antigen. Cell Immunol (1975) 0.95
Cellular regulation of gamma interferon production: Lyt phenotype of the suppressor cell. Infect Immun (1982) 0.95
The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence. J Biol Chem (1999) 0.94
IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells. Oncogene (1997) 0.94
Binding of IFN gamma and its C-terminal peptide to a cytoplasmic domain of its receptor that is essential for function. Biochem Biophys Res Commun (1994) 0.93
Clinical evaluation of a computer-based patient monitoring and data management system. Heart Lung (1991) 0.93
T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A. Proc Natl Acad Sci U S A (1992) 0.93
The IFN pregnancy recognition hormone IFN-tau blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J Immunol (1995) 0.92
Identification of IFN-gamma receptor binding sites for JAK2 and enhancement of binding by IFN-gamma and its C-terminal peptide IFN-gamma(95-133). J Immunol (1995) 0.92
Bacterial and retroviral superantigens share a common binding region on class II MHC antigens. Nature (1993) 0.92
Modulation of disease by superantigens. Curr Opin Immunol (1998) 0.92
Mechanism of calcium ionophore A23187-induced priming of bone marrow-derived macrophages for tumor cell killing: relationship to priming by interferon. Proc Natl Acad Sci U S A (1985) 0.91
Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence. J Interferon Cytokine Res (2001) 0.91
Possibility of a phase contrast electron microscope. Appl Opt (1972) 0.91
Staphylococcus aureus protein A induces the production of interferon-alpha in human lymphocytes and interferon-alpha/beta in mouse spleen cells. J Immunol (1983) 0.90
Epitope and functional specificity of monoclonal antibodies to mouse interferon-gamma: the synthetic peptide approach. J Immunol (1986) 0.90
Structural requirements for agonist activity of a murine interferon-gamma peptide. J Interferon Cytokine Res (1996) 0.90
IFN-gamma induction of p21(WAF1) is required for cell cycle inhibition and suppression of apoptosis. J Interferon Cytokine Res (1999) 0.90
Differential antiproliferative activities of IFNs alpha, beta and gamma: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs alpha and beta. J Biol Regul Homeost Agents (1989) 0.89
Both alpha-helices along the major histocompatibility complex binding cleft are required for staphylococcal enterotoxin A function. Proc Natl Acad Sci U S A (1991) 0.89
IFNgamma induction of p21WAF1 in prostate cancer cells: role in cell cycle, alteration of phenotype and invasive potential. Int J Cancer (1998) 0.89